Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Rithm Capital
RITM
$5.71B
| $2.02M | ﹤0.01% |
166,205
-1,062,600
| -86% | -$13.1M |
|
2102
Distribution Solutions Group
DSGR
$1.61B
| $2.02M | ﹤0.01% |
173,000
+45,800
| +36% | +$602K |
|
2103
Northrim BanCorp
NRIM
$599M
| $2.02M | ﹤0.01% |
303,624
+88,024
| +41% | +$623K |
|
2104
Aware
AWRE
$26M
| $2.02M | ﹤0.01% |
619,100
+16,600
| +3% | +$53.1K |
|
|
ZGNX
2105
DELISTED
Zogenix, Inc.
ZGNX
| $2.02M | ﹤0.01% |
136,887
+1,600
| +1% | +$21.5K |
|
2106
RCI Hospitality Holdings
RICK
$214M
| $2.02M | ﹤0.01% |
201,900
+58,100
| +40% | +$581K |
|
2107
Timberland Bancorp
TSBK
$361M
| $2.01M | ﹤0.01% |
162,000
+2,400
| +2% | +$28.5K |
|
|
DSCI
2108
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $2.01M | ﹤0.01% |
439,300
+158,300
| +56% | +$751K |
|
2109
Agilent Technologies
A
$41.9B
| $2.01M | ﹤0.01% |
+48,000
| New | +$1.86M |
|
2110
Cabot Corp
CBT
$4.45B
| $2M | ﹤0.01% |
49,000
+21,800
| +80% | +$862K |
|
2111
Regions Financial
RF
$26.9B
| $2M | ﹤0.01% |
+208,500
| New | +$2M |
|
|
SDLP
2112
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $2M | ﹤0.01% |
+54,836
| New | +$4.67M |
|
2113
BBVA Argentina
BBAR
$3.25B
| $2M | ﹤0.01% |
+104,700
| New | +$2.1M |
|
|
FMER
2114
DELISTED
FIRSTMERIT CORP
FMER
| $2M | ﹤0.01% |
+107,000
| New | +$2.04M |
|
2115
NovaGold Resources
NG
$3.45B
| $1.99M | ﹤0.01% |
473,000
+448,800
| +1,855% | +$1.72M |
|
|
HIL
2116
DELISTED
Hill International, Inc. Common Stock
HIL
| $1.99M | ﹤0.01% |
512,900
-11,900
| -2% | -$41.5K |
|
2117
Foster
FSTR
$405M
| $1.98M | ﹤0.01% |
145,100
-38,781
| -21% | -$528K |
|
2118
Frequency Electronics
FEIM
$858M
| $1.98M | ﹤0.01% |
186,200
+3,100
| +2% | +$32.4K |
|
|
ACAT
2119
DELISTED
Arctic Cat Inc
ACAT
| $1.97M | ﹤0.01% |
120,326
+68,326
| +131% | +$1.41M |
|
2120
Harvard Bioscience
HBIO
$28.1M
| $1.97M | ﹤0.01% |
56,680
-3,430
| -6% | -$117K |
|
2121
AstroNova
ALOT
$227M
| $1.96M | ﹤0.01% |
135,950
+1,300
| +1% | +$17.5K |
|
2122
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $1.96M | ﹤0.01% |
38,900
+23,100
| +146% | +$1.15M |
|
2123
HCI Group
HCI
$2.28B
| $1.96M | ﹤0.01% |
+56,300
| New | +$2.2M |
|
2124
NACCO Industries
NC
$317M
| $1.96M | ﹤0.01% |
203,531
+12,773
| +7% | +$130K |
|
|
INVX
2125
Innovex International
INVX
$2.15B
| $1.96M | ﹤0.01% |
+33,000
| New | +$2.05M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.